technical analysis software


Raven Industries(NASDAQ:RAVN)announced fiscal first-quarter 2018 results on Monday after the market closed, including strong growth across all segments, led by a nearly 50% increase from engineered films. Let’s take a closer look both at what drove business at the mini-industrial conglomerate as it kicked off the new fiscal year, and at what investors can expect going forward.

Raven Industries’ fish hatchery liners. Image source: Raven Industries.

Raven Industries results: The raw numbers
Metric

Fiscal Q1 2018*

Fiscal Q1 2017

Year-Over-Year Growth

Revenue

$93.5 million

$68.4 million

36.7%

Net income

technical analysis software: Avnet, Inc.(AVT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tech Data Corporation (NASDAQ: TECD) reached a deal with Avnet, Inc. (NYSE: AVT) enabling it to buy the latter's Technology Solutions business. The transaction comprises cash component of $2.4 billion and 2.785 million shares of Tech Data resulting in a total value of about $2.6 billion.

technical analysis software: Rockwell Automation, Inc.(ROK)


Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider selling last week: Aetna Inc. (NYSE: AET), Cullen/Frost Bankers Inc. (NYSE: CFR), Rockwell Automation Inc. (NYSE: ROK), Stamps.com (NASDAQ: STMP) and Western Alliance Bancorporation (NYSE: WAL).

  • [By Lisa Levin]

    Breaking news

    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected profit for its first quarter on Wednesday.
    Helmerich & Payne, Inc. (NYSE: HP) posted upbeat results for its fourth quarter.
    NetApp Inc. (NASDAQ: NTAP) reported stronger-than-expected results for its second quarter and issued strong Q3 guidance.
    Emerson Electric Co. (NYSE: EMR) proposed to acquire Rockwell Automation (NYSE: ROK) for $225 per share in cash and stock.

  • [By Ben Levisohn]

    Bernstein’s Steven Winoker looks back at 2016 for the industrial stocks he covers–Ingersoll-Rand (IR), Rockwell Automation (ROK), Eaton (ETN), and General Electric (GE) among them–and contemplates what 2017 might hold:

technical analysis software: Medtronic plc(MDT)

Advisors’ Opinion:

  • [By George Budwell, Keith Speights, and Cory Renauer]

    So, to help investors separate the wheat from the chaff, we asked our Foolish contributors which stocks they thought are worth owning until at least 2030. These three healthcare specialists recommended Medtronic (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), andIntuitive Surgical (NASDAQ:ISRG). Read on to find out why.

  • [By Matthew Briar]

    What do you get when you combine a medical device company like Medtronic plc (NYSE:MDT) and a mobile communication device like the iPhone from Apple Inc. (NASDAQ:AAPL)? You get a CardioComm Solutions Inc. (OTCMKTS:EKGGF, CVE:EKG), which can turn your smartphone into a high-powered, high-functioning heart-monitoring piece of hardware as potent as anything you’d have access to in the hospital.

    Yes, there’s a market for the melding of what Apple and Medtronic — and several other players — do. The healthcare wearable market was worth $5.1 billion in 2015, and now that such technologies are being accepted, its revenues could reach $19 billion by 2020. Meanwhile, the heart-monitoring space happens to be a market worth more than $20 billion per year, and some say it will be worth $26.7 billion by 2020. CardioComm Solutions is nestled nicely between the two of them.


    CardioComm Solutions is the name behind a brand of wellness products sold under the HeartCheck monikor. Those devices are small, handheld portable ECG (electrocardiogram) readers that put the power of a doctor’s or hospital’s heart-monitoring hardware in the hands of individuals who can use them just as effectively.

    Its flagship products are the HeartCheck ECG Pen, for consumers (available without a prescription), and the HeartCheck ECG monitoring device (available only by prescription) that’s a higher-level technology. More are on the way too. The ECG ‘Card’ is a credit-card sized device that syncs up with — and is powered by — a smartphone in close proximity. Also on the way is the HeartCheck band, which is worn on the wrist. It does a lot that the Fitbit bands do, with the added benefit of being able to produce clinical-grade ECG readouts viewable not just by the user, but by a doctor, clinic, or call center if that user chooses to deliver them remotely using the company’s platform.


    Bolstering the value proposition is the fact that all of its wares are — or will be

  • [By Ben Levisohn]

    Medtronic (MDT) has risen 1.9% to $81.75 on reports that Cardinal Health (CAH) will buy its medical supplies business.

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

technical analysis software: Ritchie Bros. Auctioneers Incorporated(RBA)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Raymond James has downgraded Ritchie Bros. Auctioneers Inc (USA) (NYSE: RBA) common stock to Market Perform

    Loop Capital's Betsy Van Hees sees storage, networking, and connectivity as the 3 reasons why Marvell Technology Group Ltd. (NASDAQ: MRVL) will return to top-Line growth. She reiterated her Buy rating and $18 price target. 

Leave a Reply

Your email address will not be published.